• LAST PRICE
    1.6300
  • TODAY'S CHANGE (%)
    Trending Down-0.0700 (-4.1176%)
  • Bid / Lots
    1.3500/ 2
  • Ask / Lots
    1.8300/ 1
  • Open / Previous Close
    1.7250 / 1.7000
  • Day Range
    Low 1.6200
    High 1.7399
  • 52 Week Range
    Low 0.8400
    High 2.2200
  • Volume
    21,931
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.7
TimeVolumeMODD
10:24 ET1001.725
10:32 ET1001.7392
10:39 ET7501.72
10:53 ET1001.69
12:03 ET54601.67
12:21 ET1001.68
12:34 ET3001.695
12:45 ET2501.7099
12:50 ET1001.68
01:10 ET2001.685
01:12 ET3001.68
01:14 ET3001.68
01:15 ET2001.68
01:17 ET3001.676
01:19 ET2001.68
01:21 ET4001.67
01:24 ET4001.67
01:26 ET2001.67
01:28 ET3001.66
01:30 ET2001.66
01:33 ET3001.66
01:50 ET1001.64
02:08 ET1001.64
02:29 ET66901.6211
02:36 ET3001.6573
02:44 ET1001.62
02:47 ET4661.6201
03:07 ET1001.62
03:36 ET1001.6599
03:45 ET2001.63
03:54 ET2001.63
03:56 ET1001.66
03:57 ET1601.64
03:59 ET5231.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMODD
Modular Medical Inc
50.5M
-1.7x
---
United StatesUEEC
United Health Products Inc
50.0M
-18.3x
---
United StatesXAIR
Beyond Air Inc
56.5M
-0.6x
---
United StatesNSPR
InspireMD Inc
49.0M
-1.9x
---
United StatesMDNC
Medinotec Inc
58.7M
-103.5x
---
United StatesLUCD
Lucid Diagnostics Inc
38.4M
-0.6x
---
As of 2024-04-20

Company Information

Modular Medical, Inc. is a development stage, medical device company. The Company is focused on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The Company, through the creation of two-part patch pump, MODD1, seeks to serve both the type 1 and type 2 diabetes markets. The Company, using its methods of insulin measurement, is able to eschew complex mechanisms and instead build a product candidate using only parts from high volume consumer electronics manufacturing lines. It provides an insulin pump, which has both basal (steady flow) and bolus (mealtime dosing) insulin disbursement. It also consists of a natural migration path to multi-chamber/multi-liquid pumps, potentially offering an array of new therapies to patients with diabetes and other conditions.

Contact Information

Headquarters
16772 WEST BERNARDO DRIVESAN DIEGO, CA, United States 92127
Phone
858-800-3500
Fax
775-786-6755

Executives

Chairman of the Board, President, Chief Financial Officer, Treasurer
Paul Diperna
Chief Executive Officer
James Besser
Chief Operating Officer
Kevin Schmid
Director
Duane Desisto
Director
Morgan Frank

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$50.5M
Revenue (TTM)
$0.00
Shares Outstanding
31.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.19
EPS
$-0.97
Book Value
$0.46
P/E Ratio
-1.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.